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The coagulation pathway of blood is
an ancient mechanism to stop leaks of
fluid from an organism. At sites of
damaged vascular endothelium, plate-
lets and neutrophils are captured from
the flow stream while tissue factor on
the wall can bind factor VIIa to initiate
a cascade of coagulation reactions on
cellular surfaces, resulting in the con-
version of prothrombin to thrombin.
The thrombin cleaves fibrinogen to an
active monomer that polymerizes to
form a fibrin meshwork. Physiologi-
cally, convection of oxygenated blood
alleviates severe diffusion limitations
that would otherwise exist in the ab-
sence of flow (i.e., blood clots would
cause heart attack and stroke). Despite
more than a century of brilliant re-
search in blood biochemistry, platelet
and vascular wall biology, suspension
rheology, and transport physics, the
complexity of blood clotting under
flow has prevented quantitative and
predictive modeling. For example,
given non-anticoagulated whole blood
of a defined genotype flowing at a
fixed wall shear rate over a defined
reactive surface, it had been impossi-
ble to predict the instantaneous rate or
final extent of platelet, neutrophil, and
fibrin deposition. In this issue, Kuhar-
sky and Fogelson (2001) have
launched the first full simulation of
platelet activation, deposition, and
cell- and wall-dependent coagulation
cascade activation during blood flow
over a tissue-factor-containing surface.
By flowing isolated platelets, neu-
trophils, or monocytes over defined
adhesive ligands attached to surfaces,
many laboratories have measured the
shear stress dependency of transient
pausing/rolling or firm arrest. How-
ever, these studies require elimination
of thrombin, which activates platelets,
as well as prevention of fibrin forma-
tion, which stabilizes platelet deposits.
The kinetics of the coagulation cascade
assembly on activated platelets (Mann
et al., 1992) and multicellular aggrega-
tion in shear flow (Laurenzi and Dia-
mond, 1999) have both been modeled;
however, these models cannot handle
spatial gradients that occur during clot-
ting on the wall.
To tackle the intertwined biochem-
istry, cell biology, and transport bio-
physics, Kuharsky and Fogelson as-
sumed the existence of a thin, well-
mixed layer near the surface. Transport
of species from whole blood into this
layer was then quantified by an overall
mass transfer coefficient, thereby elim-
inating the need to solve for spatially
dependent fluxes due to axial convec-
tion and radial dispersion. This insight-
ful approach allowed the authors to
solve 59 ordinary differential equa-
tions to simulate flowing human blood
coagulating on a reactive wall via tis-
sue factor initiation of the extrinsic
pathway. The one catch is that the use
of this well-mixed layer embeds the
flow physics into the reaction kinetics.
For example, the thickness h of this
well-mixed layer depends on velocity.
When surface densities (fmol/cm2) are
homogenized into the shell volume of
height h, the new volumetric concen-
trations (and thus reaction rates) de-
pend moderately on the flow velocity
of the simulation.
Poised between states of flowing
liquid and solid clot, the stability of
blood is predicted to be balanced on
the head of a pin (or, more literally, a
pin-prick). Increasing the tissue factor
surface density from 2 to 8 fmol/cm2
(50 sites/m2) is predicted to cause a
4- to 5-order of magnitude explosion in
the local thrombin concentration at
physiological shear rates. Given this
sensitivity, a captured neutrophil or
monocyte presenting only 100 active
tissue factor molecules on its surface
may have important consequences in
sustaining the coagulation process (Pa-
labrica et al., 1992).
Mechanisms of tissue factor inhibi-
tion (platelet coverage versus tissue
factor pathway inhibitor) were tested
through the Kuharsky-Fogelson
model. Hemophilias A and B provide
the clinical experimental situation
wherein factors VIII and IX are defi-
cient. In order to simulate impaired
coagulation after display of tissue fac-
tor to factor VIII- or IX-deficient
blood, an additional physical mecha-
nism was required—platelet deposition
blocking access of blood to the tissue
factor on the surface. In fact, the model
predicted the increased bleeding sever-
ity of hemophilia A over hemophilia
B. Importantly, the model passed an
additional test in that it predicted im-
paired coagulation under flow for
blood with reduced platelet counts, as
seen in thrombocytopenia. On the op-
posite end of the spectrum of blood
performance, a future test of the model
will be its ability to predict the factor
V Leiden phenotype, a clotting dis-
order due to a mutated factor V that
is resistant to inactivation by activated
protein C.
The Kuharsky-Fogelson model pro-
vides support for a fundamental in-
sight: platelet coverage of damaged
wall leads to the quenching of tissue-
factor-mediated thrombosis. Although
not modeled, fibrin deposits may have
a similar effect if factor X must diffuse
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through the fibrin to the tissue factor:
VIIa complex at the surface. The au-
thors support a role for the intrinsic
pathway (IXa-tenase) to continue
thrombosis after the first layer of plate-
lets are deposited over the tissue fac-
tor. Blood-borne tissue factor may also
serve this purpose (Giesen et al.,
1999), and quantitative simulation will
be useful in evaluating these issues.
Outside-in signaling alters the acti-
vation and adhesive state of the plate-
let. As a platelet is activated it can
release ADP and thromboxane, both
potent autocatalytic molecules. These
interactions are captured to a first ap-
proximation through an experimen-
tally derived rate constant for the in-
teraction of activated platelets with
unactivated platelets in a shear field.
However, the magnitude of the flow
will influence the local levels of these
highly diffusive platelet release prod-
ucts. Also, the rates of successful cell-
cell collisions, cell-surface collisions,
and fragmentation all depend on pre-
vailing flow conditions. When the re-
ceptor-ligand bond mechanics become
better characterized, the single rate
constant for platelet deposition used in
the Kuharsky-Fogelson model may
eventually be predicted for any set of
prevailing shear rates, platelet receptor
levels, and surface ligand densities.
Human blood represents a real test-
ing ground for functional genomics.
As a tissue, blood is easily obtained
and has many well-defined genetic
mutations leading to various bleeding
or clotting phenotypes. However,
blood is a tissue whose function is
always dependent on the prevailing he-
modynamics. Quantitative modeling of
blood function under flow will have
numerous diagnostic and therapeutic
uses. The model of Kuharsky and Fo-
gelson is a dramatic advancement to-
ward the development of virtual blood,
in which clotting for a genetic and
pharmacological background can be
simulated in an appropriate fluid me-
chanical context.
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